Literature DB >> 2724131

Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.

R A Bond1, A G Ornstein, D E Clarke.   

Abstract

Experiments were conducted in the isolated perfused rat kidney to determine the mechanism of unsurmountable antagonism by metergoline toward the vasoconstrictor response to 5-hydroxytryptamine (5-HT). Three possible mechanisms were investigated: 1) multiple receptors for 5-HT; 2) pseudoirreversible inhibition; and 3) allosteric modulation of 5-HT receptors. Metergoline and six other 5-HT antagonists acted as potent unsurmountable antagonists, only (-)-propranolol acted competitively (pA2 = 6.5). Multiple receptors for 5-HT were ruled out as the mechanism of unsurmountable antagonism because 5-HT and four 5-HT analogs gave similar pA2 values with (-)-propranolol. In addition, the KA value for 5-HT (185 nM) and the order and relativity of agonist potency suggest the presence of a single 5-HT2 receptor. Pseudoirreversible inhibition, over allosteric modulation of the 5-HT2 receptor, is suggested from experiments in which reversal of metergoline-induced inhibition by (-)-propranolol (studied in the presence of metergoline) was matched, in magnitude, by wash-out of metergoline. (-)-Propranolol is suggested to mimic wash-out by occupying and protecting receptors from which metergoline has dissociated. This is accomplished by virtue of its faster kinetics, on-off the 5-HT receptor, allowing restoration of 5-HT responses via a competitive interaction. Pseudoirreversible antagonism, over allosteric receptor modulation, offers an explanation that does not involve the postulation of allosteric effector sites or changes in the state of the 5-HT2 receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2724131

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.

Authors:  I Sahin-Erdemli; P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

2.  Multiple 5-HT receptors in the guinea-pig superior cervical ganglion.

Authors:  C J Watkins; N R Newberry
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum.

Authors:  D A Craig; R M Eglen; L K Walsh; L A Perkins; R L Whiting; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

4.  The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.

Authors:  K A Wardle; E S Ellis; G S Baxter; G A Kennett; L M Gaster; G J Sanger
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.

Authors:  H Pertz; E Eich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

6.  Dissociation of the antimicrobial activity of bacitracin USP from its renovascular effects.

Authors:  G Drapeau; E Petitclerc; A Toulouse; F Marceau
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

7.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Characterization of a serotonin receptor endogenous to frog melanophores.

Authors:  M N Potenza; M R Lerner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

9.  The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.

Authors:  A Lucchelli; M G Santagostino-Barbone; A Barbieri; S M Candura; M Tonini
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.